Publikationen in Zusammenarbeit mit Forschern von Instituto de Investigación Sanitaria Biobizkaia (86)

2023

  1. Clinical and Treatment Outcome Differences Between the Most Common Nontuberculous Mycobacteria (NTM) in the Basque Country

    Archivos de Bronconeumologia, Vol. 59, Núm. 11, pp. 765-767

  2. Coronavirus Disease 2019 in Rheumatic Patientswith Inflammatory Disorders: A Descriptive Study from a High Infection Incidence Region of Northern Spain

    EUROPEAN JOURNAL OF RHEUMATOLOGY, Vol. 10, Núm. 4

  3. Correction: Vitamin C and folate status in hereditary fructose intolerance (European Journal of Clinical Nutrition, (2022), 76, 12, (1733-1739), 10.1038/s41430-022-01178-3)

    European Journal of Clinical Nutrition

  4. Decoding the molecular heterogeneity of pediatric monomorphic post–solid organ transplant lymphoproliferative disorders

    Blood, Vol. 142, Núm. 5, pp. 434-445

  5. Experiences and impact on the quality of life of people with long COVID

    Gaceta Sanitaria, Vol. 37

  6. Impact of the “Looking after my health after cancer” peer-led active patient education program on cancer survivors and their caregivers: A qualitative study

    PLoS ONE, Vol. 18, Núm. 2 February

  7. Mortality Risks after Two Years in Frail and Pre-Frail Older Adults Admitted to Hospital

    Journal of Clinical Medicine, Vol. 12, Núm. 9

  8. Psychosis and substance abuse increase the COVID-19 mortality risk

    Psychological Medicine, Vol. 53, Núm. 9, pp. 4236-4244

  9. The polygenic basis of relapse after a first episode of schizophrenia

    European Neuropsychopharmacology, Vol. 75, pp. 80-92

  10. Variations and different perceptions in vitamin D supplementation in the pediatric age in Spain

    Pediatria de Atencion Primaria, Vol. 25, Núm. 97, pp. e1-e13

  11. m6A levels and expression of its modification genes show significant differences in breast cancer molecular subtypes

    Genes and Diseases, Vol. 10, Núm. 5, pp. 1751-1754

  12. microRNA sequencing for biomarker detection in the diagnosis, classification and prognosis of Diffuse Large B Cell Lymphoma

    Scientific reports, Vol. 13, Núm. 1, pp. 12159